WHO Releases Global Tuberculosis Report 2012

Click here to read full report.

The WHO released the Global Tuberculosis Report 2012 today. The main take home points are:

  • In the space of 17 years, 51m people were successfully treated for TB saving 20m lives.
  • TB rates worldwide are decreasing but the overall burden remains huge with drug-resistance becoming more and more of a challenge. Asia is the hardest hit region with the largest numbers of TB cases with the majority in China and India. Africa and Europe are not seeing rates decline as quickly as other regions.
  • The new statistics highlight the urgent need for new tools, such as new drugs, new diagnostics, and new vaccines ,to significantly impact the burden of TB and reach the goals outlined in the Global Plan to Stop TB.
  • Funding for tuberculosis research and implementation needs to increase to address this disease that is still killing over a million people a year. Current funding levels are just inadequate.

Additional Coverage:

In new report, WHO warns global fight against TB now at a crossroads

TB rates down, but its ‘global burden’ remains huge, WHO reports

World TB cases fall, but drug-resistance a worry: WHO

Tuberculosis effort in real danger – WHO

More News
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...
4 May 2022
Earlier this week, the World Health Organization (WHO) released a rapid communication which detailed the upcoming changes to the treatment guidance for drug-resistant tuberculosis (DR-TB). These guidelines are used to inform national TB programmes globally on how to treat patients with these...